- Retour au menu
- Retour au menuTarifs
- Retour au menuRecherche
- Retour au menuConsensus
- Retour au menu
- Retour au menu
- Retour au menu
- Retour au menuWebinaires et Événements
Latest from Michael J. Casey
The DeFi, CeFi Debate: How Should Each Be Regulated?
In the wake of high-profile business failures in the sector many in the crypto industry now call “CeFi,” and the hacks that have plagued “DeFi,” (alternative decentralized platforms), what should regulators do to protect investors? “Money Reimagined” hosts Michael Casey and Sheila Warren dive into this debate with Immunefi CEO Mitchell Amador and Timothy Massad, Harvard University Kennedy School of Government Senior Fellow and former CFTC Chairman.

La CeFi a fait faillite. Mais la DeFi n'est pas exempte de reproches.
Il est dangereux de rejeter toute la responsabilité du chaos actuel sur les prêteurs centralisés. Des efforts sont nécessaires pour assurer la sécurité et la stabilité de la DeFi, déclare le directeur du contenu de CoinDesk.

The Power of Blockchain Education in High-Growth Economies
To drive blockchain adoption, many in the industry say that education is critical. But how should it be provided, particularly in underserved communities? Interesting examples can be found in high growth economies embracing the technology. “Money Reimagined” hosts Michael Casey and Sheila Warren explore this topic with Oluwaseun David Adepoju, head of research at the Africa Blockchain Institute, and Rhonda Eldridge, founder of Harness All Possibilities.

Besoin d'un cas d'utilisation pour la décentralisation ? Commencez par l'énergie.
En plein marché baissier, l'industrie des Crypto et de la blockchain doit démontrer son utilité. Le système énergétique dysfonctionnel est un bon terrain pour s'imposer, affirme le directeur du contenu de CoinDesk.

How DAOs and Blockchain Technology Can Impact Medical Treatments
Can decentralized organizations help lower the costs of medications and accelerate medical research? Money Reimagined host Michael Casey sits down with Genetic Networks Founder & Chairman Gennaro D’Urso to talk about his efforts to change the inefficiencies of big pharma.
